Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes
eLife · 2023
DOI: 10.7554/elife.71154 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Amanda R Dicks und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Washington University in St. Louis, St Louis, United States. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Osteochondrodysplasias. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Mutations in the TRPV4 ion channel can lead to a range of skeletal dysplasias. However, the mechanisms by which TRPV4 mutations lead to distinct disease severity remain unknown. Here, we use CRISPR-Cas9-edited human-induced pluripotent stem cells (hiPSCs) harboring either the mild V620I or lethal T89I mutations to elucidate the differential effects on channel function and chondrogenic differentiation. We found that hiPSC-derived chondrocytes with the V620I mutation exhibited increased basal currents through TRPV4. However, both mutations showed more rapid calcium signaling with a reduced overall magnitude in response to TRPV4 agonist GSK1016790A compared to wildtype (WT). There were no differences in overall cartilaginous matrix production, but the V620I mutation resulted in reduced mechanical properties of cartilage matrix later in chondrogenesis. mRNA sequencing revealed that both mutations up-regulated several anterior HOX genes and down-regulated antioxidant genes CAT and GSTA1 throughout chondrogenesis. BMP4 treatment up-regulated several essential hypertrophic genes in WT chondrocytes; however, this hypertrophic maturation response was inhibited in mutant chondrocytes. These results indicate that the TRPV4 mutations alter BMP signaling in chondrocytes and prevent proper chondrocyte hypertrophy, as a potential mechanism for dysfunctional skeletal development. Our findings provide potential therapeutic targets for developing treatments for TRPV4-mediated skeletal dysplasias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Washington University in St. Louis, St Louis, United States.
- Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, St Louis, United States.
- Shriners Hospitals for Children - St. Louis, St. Louis, United States.
- Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, St Louis, United States.
- Department of Mechanical Engineering and Material Science, Washington University in St. Louis, St. Louis, United States.
- Department of Neurology, Duke University School of Medicine, Durham, United States.
ORCID-Profile: Amanda R Dicks, Colin G Nichols, Chia-Lung Wu, Farshid Guilak
Förderung
- NIAMS NIH HHS
- NIDDK NIH HHS
- NIA NIH HHS
- NHLBI NIH HHS
- NIBIB NIH HHS
- NCATS NIH HHS
- National Institutes of Health
Zitieren
APA
Dicks, A. R., Maksaev, G. I., Harissa, Z., Savadipour, A., Tang, R., Steward, N., Liedtke, W., Nichols, C. G., Wu, C. L., & Guilak, F. (2023). Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes. eLife. https://doi.org/10.7554/elife.71154
Vancouver
Dicks AR, Maksaev GI, Harissa Z, Savadipour A, Tang R, Steward N, et al. Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes. eLife. 2023. doi:10.7554/elife.71154
BibTeX
@article{Dicks2023,
author = {Dicks, Amanda R and Maksaev, Grigory I and Harissa, Zainab and Savadipour, Alireza and Tang, Ruhang and Steward, Nancy and Liedtke, Wolfgang and Nichols, Colin G and Wu, Chia-Lung and Guilak, Farshid},
title = {Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.71154}
}
EUVIMED